Präparat: IBRANCE® 75 mg/ -100 mg/ -125 mg Hartkapseln
Czerwona Lista / Rote Liste®
Search in Czerwona Lista / Rote Liste®
All databases
IBRANCE® 75 mg/ -100 mg/ -125 mg Hartkapseln
This content is only available to registered users
If you’re visiting this website the first time and would like to test the database free of charge for ten days, then click here to register once. After you’ve registered, log in with your user name and password.You’re already registered with DrugBase and would like to test the database free of charge for ten days without any further commitment? Then log in here with your access data and select the database you wish to test.
Hauptgruppe
86: Zytostatika, andere antineoplastische Mittel und Protektiva
> 86.1: Antineoplastische Mittel
> 86.1.B: Chemisch definierte antineoplastische Mittel
> 86.1.B.1: Einzelstoffe
> 86.1.B.1.5: Andere antineoplastische Mittel
>
86.1.B.1.5.6: Proteinkinase-Inhibitoren
...
...
Hersteller
Zentrale Zulassung
...
Anwendungsgebiete
...
Gegenanzeigen
...
Anwendungsbeschränkungen
...
Schwangerschaft
...
Stillzeit
...
Nebenwirkungen
...
Wechselwirkungen
...
Intoxikationen
...
Warnhinweise
...
Hinweise
...
Dosierung
...
Copyright
© Rote Liste® Service GmbH, ROTE LISTE® 2020
